Short answer · Medically reviewed summary · Last updated: 2026-04-07
Sotos syndrome is classified under the ICD-10-CM code Q87.3 (congenital malformation syndromes with overgrowth) and was previously categorized under the ICD-9-CM code 759.89 (other specified congenital anomalies). These diagnostic codes are essential for medical billing, insurance documentation, and tracking the clinical management of patients with this rare overgrowth disorder. What is the clinical classification of Sotos syndrome? Sotos syndrome, often referred to as cerebral gigantism, is a rare genetic disorder characterized by excessive physical growth during the first years of life, distinctive facial features, and varying degrees of intellectual disability.
Sotos syndrome is classified under the ICD-10-CM code Q87.3 (congenital malformation syndromes with overgrowth) and was previously categorized under the ICD-9-CM code 759.89 (other specified congenital anomalies). These diagnostic codes are essential for medical billing, insurance documentation, and tracking the clinical management of patients with this rare overgrowth disorder.
Sotos syndrome, often referred to as cerebral gigantism, is a rare genetic disorder characterized by excessive physical growth during the first years of life, distinctive facial features, and varying degrees of intellectual disability. Because it is a complex, multi-system condition, clinicians utilize the ICD-10 code Q87.3 to capture the overarching diagnosis of congenital overgrowth syndromes. While ICD-9 codes are largely retired in modern clinical practice, the legacy code 759.89 remains significant for historical medical records and longitudinal research involving individuals diagnosed with Sotos syndrome prior to the transition to ICD-10.
The primary cause of Sotos syndrome is a mutation or deletion in the NSD1 gene, located on chromosome 5 (5q35.3). This gene is responsible for producing a protein that acts as a histone methyltransferase, which plays a critical role in normal growth and development. In approximately 75% to 90% of cases, Sotos syndrome occurs as a de novo (sporadic) event, meaning it is not inherited from either parent. However, in rare instances, it can be inherited in an autosomal dominant pattern. Understanding the genetic basis is vital for families, and our community at DiseaseMaps.org, where 98 people with Sotos syndrome have shared their experiences, serves as a crucial resource for peer-to-peer support regarding genetic testing and counseling.
Diagnosis of Sotos syndrome is primarily clinical, based on the presence of the "classic triad": overgrowth (height, weight, and head circumference typically above the 97th percentile), characteristic facial features (such as a long, narrow face and prominent forehead), and developmental delays. Confirmation is achieved through molecular genetic testing. Key clinical features often include:
While the overgrowth associated with Sotos syndrome typically slows down by puberty, the long-term management of the condition requires a multidisciplinary approach. Patients often benefit from regular follow-ups with pediatricians, neurologists, and endocrinologists to manage potential complications. From a psychological perspective, children with Sotos syndrome may face social challenges due to their size, and early intervention services are highly recommended to support cognitive and physical development. Connecting with others through platforms like DiseaseMaps.org can help families navigate the complex healthcare landscape and advocate for necessary school and medical accommodations.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.